You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

PROKERA® biologic corneal bandage devices are used around the world to heal and treat ocular conditions such as keratitis, moderate to severe dry eye disease, recurrent corneal erosions, filamentary keratitis, persistent epithelial defects, neurotrophic corneas, herpetic ulcers, and many other ocular surface diseases such as chemical burns and Stevens-Johnson syndrome.

    PROKERA® is proven to:
  • Reduce harmful inflammation
  • Minimize scarring
  • Improve corneal nerve regeneration
  • Accelerate ocular-surface recovery.

PROKERA® is manufactured with a proprietary cryopreservation method called CryoTek® that ensures the tissue retains its full biologic and structural equivalent to fresh tissue. Cryopreserved Amniotic Membrane or “CAM” products are the only amniotic membrane devices cleared by the FDA as class II medical devices and are designated as having anti-inflammatory, anti-scarring and anti-angiogenesis properties.

The CryoTek process is the ONLY method proven to effectively retain the Heavy Chain Hyaluronic Acid/Pentraxin3 (HC-HA/PTX3) complex, which has been demonstrated to orchestrate an environment that promotes regenerative healing. CryoTek-processed tissues are also the only available placental allografts that have been shown to be equivalent to fresh placental tissue and superior to other available placental allografts that are provided in a dehydrated state.

Early intervention with PROKERA® supports the restoration of the cornea’s healing capabilities, reducing inflammation, preventing scarring, improving corneal health and optimizing long-term outcomes.

    PROKERA® is supported by:
  • 30 continuous years of NIH research grants,
  • 350 peer-reviewed publications
  • 20 years or proven clinical performance and >300,000 human transplants.
Contact Us for More information